Use of 5-Fluorocytosine in Patients with Impaired Renal Function

British Medical Journal

Volumn 4, Issue 5889, 1973, Pages 382-

  Dawborn, J K ^a   Page, M D ^a   Schiavone, D J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCYTOSINE;

CANDIDIASIS; CREATININE CLEARANCE; DRUG CLEARANCE; DRUG EXCRETION; DRUG HALF LIFE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MYCOSIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; PLASMA; THERAPY;

ANTIFUNGAL AGENTS; CREATININE; CYTOSINE; FLUCYTOSINE; HALF-LIFE; HUMAN; KIDNEY; KIDNEY DISEASES;

EID: 0015894592     PISSN: 00071447     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.4.5889.382     Document Type: Article

References (3)

1. Koechlin, B. A., Rubio, F., Palmer, S., Gabriel, T., and Duschinsky, R. (1966). Biochemical Pharmacology, 15, 435.
2. Schiavone, D. J., Page, M., and Dawborn J. K. (1973). British Medical Journal, 4, 380.
3. Wade, D. N., and Sudlow, G. (1972). Australian and New Zealand Journal of Medicine, 2, 153.